Semaglutide FDA - Search News

Drug compounders sue FDA over semaglutide status

Hosted on MSN · 4d

Semaglutide shortage ends as FDA sets deadline for compounders

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions of semaglutide are no longer allowed – for now.

FDA Announces End to Semaglutide Shortage, Impacting Compounders and Telehealth Providers Offering Injectable GLP-1 Drugs

Last week, the US Food and Drug Administration (FDA) announced the end of a years-long shortage of semaglutide injection products — a

The Hill on MSN · 2d

Drug compounders sue over weight loss drugs’ removal from FDA shortage list

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug shortage list.

7don MSN

FDA says Ozempic shortage is over, chilling boom in off-brand versions

The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Top in endocrinology: Semaglutide shortage ends; rise in diabetes in low-income countries

The FDA recently removed semaglutide from its drug shortage list, which has not been considered commercially available since ...

Lilly expands its Zepbound vial offering, as Hims pulls back on semaglutide

Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...

2d

Hims & Hers: Brace For Impact As It Faces A Possible 18% Revenue Hit

Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results